Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q2 EPS of ($0.46), in-line with the analyst estimate of ($0.46).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.